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Formation and characterization of 
FeLV ISCOMs 
L..~kerblom*, K. Str6mstedt t, S. H6glund:, A. Osterhaus ~ and B. Morein'* 
Immunostimulating complexes (ISCOMs) have been prepared from feline leukaemia virus 
(FeLl:) envelope proteins. The ISCOMs were characterized biochemically in SDS-poly- 
acrylamide gel electrophoresis howing the presence of proteins of estimated molecular weights of 
15 000, 27 000 and 70 000. Immunoblotting showed that both the transmembrane protein p l 5E and 
the external glycoprotein gp70 (making up the gp85 protein) were present in the ISCOM. 
Furthermore, a degradation product of gp70 with an estimated molecular weight of 32000 was 
identified in the immunoblot. The FeL V ISCOM was shown by electron microscopy to have the 
characteristic cage-like structure of an ISCOM with a mean diameter of 37 nm. About 10% of the 
total amount of gp70 in the culture fluid was recovered in the ISCOMs. The largest loss was 
encountered during the sedimentation of the virus. In a preliminary immunization experiment in 
mice the FeL V ISCOMs elicited after a booster gave a clear-cut immune response against gp70. 
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Introduction 
Feline leukaemia virus (FeLV) belongs to the Retro- 
viridae family, subfamily Oncovirinae. It has a world- 
wide distribution and may cause leukaemia in cats, but 
more often it causes an immunodeficiency syndrome. It is 
considered that the protective antigen is the glycosylated 
envelope protein with a molecular weight of 70 000 (gp70) 1. 
Like most other etroviruses, the envelope of FeLV is first 
formed as a precursor protein (gp85). This is cleaved with 
a trypsin or a trypsin-like cellular enzyme of gp70 and 
pl5E during intracellular t ansport to the plasma mem- 
brane before budding out with the virus particle. Gp70 
being the peripheral part of the envelope protein, is to a 
great extent detached from the transmembrane protein 
p 15E and the virus particle, and is found in the cell culture 
medium; pl5E, however, remains integrated in the virus 
envelope. 
Recently it was shown in an immunization experiment 
in cats by Osterhaus et al. 2.3 that gp70 integrated into an 
immunostimulating complex (ISCOM) 4 could induce pro- 
tection to challenge infection in cats. The immunization 
experiment was extended to a larger experiment including 
140 cats 3'5. In this experiment about 85% of the ISCOM- 
immunized cats developed virus-neutralizing antibodies, 
available vaccine developed neutralizing antibodies. It
had earlier been shown by Essex et al. 6 and later by 
others 7.s that cats with neutralizing antibodies to FeLV do 
not develop disease, i.e. they have protective immunity to 
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FeLV. It has also been shown with a monoclonal anti- 
body that gp70 contains at least one neutralizing epitope 
and that this epitope is conserved in the three known 
serotypes. 
In the present work we describe the preparation of 
ISCOMs containing FeLV gp70, and we characterize 
them as regards their morphology, their content of gp70, 
pl5E and a breakdown product of gp70 migrating as a 
32000 molecular weight protein in an SDS-polyacryl- 
amide gel electrophoresis. A preliminary immunization 
study in mice is also documented and the prospects of a 
vaccine are discussed. 
Materials and methods 
Materials 
The detergent MEGA-10 (n-decanoyl-methyl gluc- 
amine) 9 was synthesized according to the method of 
Hildreth 1°. MEGA-10 was used as a 20% stock solution 
in water. Quil A 'Spikoside' was from Iscotec AB (LuleL 
Sweden). Quil A was used as a 10% stock solution in 
water. The crosslinker DTNP (dithiobis-m-nitropyridine) 
was used as a 0.2% stock solution in DMSO'. 
Antisera. A mouse monoclonal antibody (mAb) 
against gp702 was used in the detection and purification 
of gp70. A hyperimmune antiserum against pl5E from 
Raucher murine leukaemia virus was a generous gift from 
Dr Oswald Jarrett, Glasgow, Scotland. 
Cells and virus. The cat T-lymphoma cell line F42212 
was used for the propagation ofFeLV. Cells were grown 
in RPMI 1640 (The National Veterinary Institute, Sweden) 
supplemented with 10% fetal calf serum, 100 IU penicillin 
and 100 Ixg streptomycin m1-1. Cultures up to 5 litres were 
grown in Roller bottles or in Spinner culture flasks. 
Larger volumes of cultures were run in a fermenter quip- 
ment from Chemoferm AB, Sweden. Harvested cell cul- 
ture fluid was freed from cells and cell debris by low-speed 
centrifugation at 4000 rev min -~ for 30 min in a Sorvall 
rotor GS3. The supernatant was collected and concen- 
trated 10--15 times by ultrafiltration through a pellicon 
filter (Millipore PTMK 00005) with an exclusion limit of 
300 000. From the concentrate he virus was sedimented 
at 20000revmin -1 for 2h at 10*C in a Kontron TFA 20 
rotor. The virus pellet was suspended in 10 ml 0.5 ra Tris, 
0.15 M NaCI pH 7.5 (TN) and layered over a 30% sucrose 
cushion. The virus was centrifuged at 28 000 rev min -~ for 
2 h at 10°C in a Kontron TST 28.38 rotor. This step was 
avoided for some virus batches in an effort to minimize 
the loss of gp70, due to shearing forces during centrifu- 
gation. From the stock solution the crosslinker (DTNP) 
was added to a concentration f0.02% and incubated for 
30 min at room temperature to stabilize the binding of 
gp70 to the membrane anchoring part, p 15E. 
Me~o~ 
Labelling of virus glycoproteins. To dividing F422 
cells were added 400 ~tCi glucosamine (TRK.398, Amer- 
sham), in 250ml RPMI 1640 medium free from glucose 
and supplemented with 10% fetal calf serum, over 24 h. 
Formation oflSCOM. This was essentially performed 
as described before 4. To a virus sample of approximately 
200 mg in 8 ml TN, 0.9 ml of the stock solution of MEGA 
was added to a final concentration of 2% and left for 2 h 
at room temperature. The solubilized virus was layered on 
top of 10% sucrose in TN in a volume of 2 ml containing 
MEGA at a concentration of 0.2%, with a layer of 30% 
sucrose in TN underneath. The solubilized virus was 
centrifuged at 30 000 rev per min for 2h at 20"C in a 
TST.41.14 rotor. The top fraction consisting of the sample 
volume plus the 10% sucrose layer was collected and 
Quil A was added to a concentration of 0.1%. The mix- 
ture was extensively dialysed against TN. 
SDS-polyacrylamide gel electrophoresis. This was 
done in a 12% gel according to Laemmli 13. 
Western blots. These were done according to Towbin 
et al. ~4 using nitrocellulose filter paper from Schleicher &
Schiill, FRG. 
Purification ofgpTO. FeLV gp70 was purified by an 
immunosorbent technique from culture fluid media or 
from infected cells. A monoclonal antibody recognizing a 
neutralizing epitope on gp702 was coupled to CNBr- 
activated sepharose (Pharmacia, Sweden) following the 
manufacturer's description. Gp70 was eluted with 0.1 
Tris pH 11.0. Fractions containing protein were adjusted 
to pH 8.0 with 1 M HC1. 
Quantification ofgpTO. A quantitative dot-immuno- 
blot using afffinity-purified gp70 and a monoclonal anti- 
gp70 antibody were used to determine the amount ofgp70 
in virus and ISCOMs. In the dot-immunoblot analysis a 
nitrocellulose filter holder from Bio-Rad (USA) was used. 
Fluorography. To analyse the glycoprotein content of 
a virus preparation, virus labelled with tritiated gluco- 
samine was electrophoresed in SDS-PAGE gels and 
soaked in scintillator fluid (Amplify, Amersham, Eng- 
land). The gel was dried. The radioactivity pattern was 
analysed by fluorography using Kodak X-AR 5 film. 
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Protein determination. This was performed by the 
method of Bradford ~5 using bovine serum albumin as 
standard. 
ELISA. The ELISA ~6 was performed in microtitre Im- 
munoplates I (Nunc, Roskilde, Denmark). The plates 
were coated overnight at 4"C with either highly purified 
gp70 at a concentration of 1 ~tgml -~ or with FeLV 
ISCOMs at a concentration f 3 ~tg ml -~ in 50 mM carbon- 
ate buffer pH 9.6. All washings were made with phos- 
phate-buffered saline (150 mM, pH 7.5) containing 0.2% 
Tween-20 (PBS-Tween). The plates were blocked with 
5% dried milk in PBS-Tween for 1 h at 37°C. Antisera 
were diluted in PBS-Tween and incubated for I h at 37 °C. 
Horseradish peroxidase conjugated rabbit anti-mouse and 
swine anti-rabbit (Dakopatts, Copenhagen, Denmark) 
were diluted 1:1000 in PBS-Tween and incubated for 1 h 
at 37 °C. The enzyme reactions were visualized with tetra- 
methylbenzidine (0.19 mg ml -~) (Sigma, USA) and H202 
(0.006%) in 0.1 ~ acetate buffer pH 6.0 and absorbance 
was measured at 450 nm with a Titertek Multiscan spectro- 
photometer (Flow Laboratories, Irvine, Scotland). 
Electron-microscopic analysis. Samples of ISCOMs 
were applied to hydrophilic, carbon-coated grids. For 
dialysis the specimens were placed upside down on micro- 
droplets of 0.1 M phosphate buffer, pH 7.0 before negative 
staining with ammonium molybdate, pH 7.0. The speci- 
mens were studied in a Philips 300 electron microscope at 
60 kV accelerating voltage to improve the contrast effect. 
Photographs were taken in through focal series with 
minimal beam exposure. 
Results 
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FeLV originating from the cat T-lymphoma cell line 
F422 was concentrated and enriched by centrifugation. 
The virus material was solubilized with the detergent 
MEGA and the envelope proteins were integrated into 
ISCOMs by the dialysis method. 
Recovery. The amount of the envelope protein gp70 
was estimated at different steps of purification by a quan- 
titative dot-immunoblot method using a monoclonal anti- 
gp70 antibody with highly purified gp70 as a standard. 
The purification steps include: (1) concentration by ultra- 
filtration where little loss occurred; (2) sedimentation f
virus by two centrifugations where most of the gp70 was 
lost, approximately 70% ; (3) the preparation of ISCOMs 
with a centrifugation and a dialysis procedure where an 
additional 20% of the gp70 was lost. The remainder is 
< 10°/0 of the amount ofgp70 of the starting material. The 
detailed results are given in Table 1. 
Table 1 Relative recovery of gp70 at different steps of virus purification 
and ISCOM preparation as measured by a quantitative dot-immunoblot 
method 
Percentage recovery 
of gp70 from 
Different steps in the purification of virus Original Preceding 
and formation of ISCOMs material step 
Tissue culture fluid from FeLV-infected cells 100 100 
Ultrafiltration 90-100 90-100 
Pelleted virus 30 30-33 
ISCOM 5-10 17--33 
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Electron-microscopic evaluation of FeLV ISCOMs. 
A relatively homogeneous population of ISCOM par- 
ticles was observed by electron microscopy (Figure 4), 
demonstrating a characteristic cage-like structure. The 
diameter of the projections of ISCOM varied from 30 to 
45 nm with a mean diameter of 37 nm. When ISCOM par- 
a b 
p32 
p27 ~ 
p32 
p15 =, 
Figure 1 Analysis of FeLV and FeLV ISCOMs in SDS-polyacrylamide gel 
electrophoresis and in Western blot for the presence of the envelope 
protein gp70. (a) SDS-PAGE gel analysis of FeLV ISCOMs; (b) Western blot 
analysis of virus lysate using an anti-gp70 mAb; (c) Western blot analysis 
of FeLV ISCOMs using an anti-gp70 mAb; (d) autoradiogram of affinity- 
purified [3H]glucosamine-labelled gp70 separated in an SDS-PAGE gel 
p15E~ 
Pr15E 
The protein pattern of the FeL V ISCOM. This was 
analysed in an SDS-PAGE and Western blot as described 
in Materials and Methods (Figure 1). Several protein 
bands are visible. The two most prominent bands in the 
ISCOM preparation migrated as proteins with molecular 
weights of 15 000 and 27 000 respectively. They probably 
represent the gag-coded proteins p15 and p27. Besides 
detecting a protein in the 70 kDa region, the monoclonal 
antibody to gp70 also identified a band in the 32 kDa 
region of the PAGE of the virus as well as of the ISCOM 
(Figure lb, c). The 70 and 32 kDa bands were also iden- 
tified by fluorography with immunosorbent-purified 
[3H]glucosamine-labelled gp70 separated in SDS-PAGE 
(Figure ld). 
By Western blot analysis the transmembrane protein 
pl5E was detected in virus and ISCOMs using rabbit 
hyperimmune antiserum. Two bands were detected in the 
virus lysate, but in the ISCOM preparation only the 15 k 
band was visible (Figure 2). 
ELISA analysis of FeLV ISCOMs. The FeLV 
ISCOMs were tested as antigen in ELISA against amono- 
clonal antibody to gp70 and against arabbit anti-serum to 
pl5E (Figure 3). The reading was plotted against he 
recriprocal ntibody dilutions expressed as a natural log- 
arithm. The behaviour and the slope of the curves for the 
two antisera are similar, indicating equal amounts of 
pl 5E and gp70 in the ISCOM preparation. 
Figure 2 Western blot analysis of FeLV ISCOMs (a) and FeLV lysate 
(b) using a rabbit hyperimmune anti-p15E antiserum 
1.5 
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Figure 3 Analysis of FeLV ISCOMs in ELISA for the presence of gpT0 and 
p15E. The ELISA plates were coated with FeLV ISCOMs and incubated 
with different dilutions of the anti-gp70 mAb (o) and the anti-p15E anti- 
serum (11) (see Materials and methods) 
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Figure 4 Electron microscopy of FeLV ISCOMs (a) Electron micrograph 
of ISCOM particles, negatively stained by ammonium molybdate, showing 
projections of cage-like structures ( x 125 OOO) A central, ring-like subunit 
of the shell of the ISCOM is shown in different projections in the insert, also 
demonstrated by the drawings. (b) Histogram of the distribution of the 
diameter of the projection of negatively stained ISCOM particles with an 
arithmetic mean value of 37 nm 
ticles in different ilt angles were analysed they appeared 
slightly flattened. 
Immunization of mice with FeL V ISCOMs. In a pre- 
liminary study two sets of five mice were immunized with 
FeLV ISCOMs with a total protein dose of 0.3 and 3.0 I~g 
respectively. The gp70 content of FeLV ISCOMs in this 
study was estimated to be 5% of the total protein con- 
tent corresponding to a dose of 15 and 150 ng of gp70 
respectively. 
The serum titres were tested against highly purified 
gp70 in an ELISA. Low but clear-cut serum titres were 
detected against gp70 by this assay. The end dilution titres 
for the two sets of mice after the first and second immu- 
nization were as shown in Figure 5. 
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Discussion 
Like most retroviruses, the peripheral and glycosylated 
part of the envelope protein gp70 of FeLV detaches from 
the anchoring and transmembrane part--pl 5E. This fact 
makes it difficult to isolate and to assemble gp70 to 
micelles, or to ISCOMs, by hydrophobic interactions to 
enhance its immunogenicity. The necessity of presenting 
immunogens in defined physical forms with multimeric 
presentation fthe antigen has been reviewed 17. The most 
immunogenic ofsuch complexes seems to be the ISCOM 18. 
However, an experimental ISCOM vaccine based on gp70 
has already been shown to protect cats against challenge 2. 
This vaccine was essentially prepared as described here, 
with a high amount of starting material and a low yield. 
From Table 1 it is evident hat the major loss of gp70 
antigen occurs during the centrifugation steps. The mono- 
meric, highly water-soluble gp70, with a comparatively 
low sedimentation coefficient, is readily separated from 
the faster-sedimenting virus particle. The addition of 
DTNP, which is used with the intention of stabilizing 
disulphide linkage between plSE and gp7011, did not 
prevent a major loss of remaining p70. In the procedure 
used here, DTNP had to be added after the first centri- 
fugation to avoid precipitation. It might be worth testing 
whether DTNP is more useful if the first centrifugation is 
replaced with another concentration a d purification step. 
The final recovery of gp70 (in our procedure for making 
ISCOM) was ~< 10% and virtually all losses occurred 
during the virus-isolation procedures, as found with the 
preparation of ISCOMs with gpS1 of bovine leukaemia 
virus19. Therefore, alternative methods for making im- 
munogenic complexes based on hydrophobic nteractions 
such as protein micelles or virosomes would not solve this 
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Figure 5 Serum antibody titres to gp70 in mice immunized with FeLV 
ISCOMs as measured by ELISA. Arrows show first and second vaccination 
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problem. An efficient way to preclude described losses of 
gp70 is by use of an animal cell producing the complete 
envelope protein gp85, e.g. after transfection with an 
animal cell vector cloned with the env gene where the 
cleavage region of gp70 is deleted. The product of such a 
construct of the env gene for gpl60 of HIV was efficiently 
integrated into ISCOMs. 
The ISCOM preparation was analysed in PAGE and 
Western blot. In the PAGE the most prominent virus 
bands of virus proteins eem to be p l 5 and p27, while 
gp70 and pl 5E are less prominent. In the Western blot, on 
the other hand, gp70 and p15E respectively are readily 
recognized with a monoclonal ntibody (gp70), which is 
recognizing a neutralizing epitope, and a polyclonal 
serum (pl5E). This antibody (anti-gp70) is, therefore, 
potentially useful as a quality control tool for this ex- 
perimental vaccine, as described by Merza et al. 19, who 
used neutralizing monoclonal antibodies to control an 
experimental BLV vaccine. The ISCOM preparation de- 
scribed here reacted also in ELISA with this antibody 
under a less denaturing condition than the Western blot. 
In the Western blot this antibody, as well as detecting a 
band migrating as a 70 kDa protein in the SDS-PAGE, 
also detected a 32 kDa band. This band was present both 
in the virus particle preparation and the ISCOM. It is 
probably asplit or degradation product of gp702° and less 
is found in freshly prepared virus or ISCOMs than in 
older preparations. The other split product with an ex- 
pected molecular weight of 30 000-40 000 has not yet been 
identified. FeLV ISCOMs comprising different proteins 
were analysed by electron microscopy by a size distri- 
bution of the ISCOM particles. Although somewhat flat- 
tened, as judged by different ilt projections in electron 
microscopy (Figure 4a), a variation in diameter (Figure 
4b) may reflect a variation in volumes of the ISCOMs. 
The proteins in the shell of the cage-like ISCOM were 
efficiently exposed. 
Another interesting observation is that the antibody 
recognizing pl5E recognized two bands in the virus prep- 
aration but not in the ISCOM. The additional band has a 
slightly higher molecular weight in SDS-PAGE and may 
represent a precursor protein to plSE, as described for 
murine leukaemia virus 21. The rabbit anti-Raucher pl5E 
coprecipitates two proteins with estimated molecular 
weights of 12 kD and 15 kD. The presence of p l 5E was 
necessary for the coprecipitation with gp70. Virus prep- 
arations from F422 cells lacked p15E, but contained 
pl2E, and failed to coprecipitate gpT0 z2. This might ex- 
plain the low yield of gp70 recovered from virus produced 
by F422 cells. 
In a dilution experiment with the monoclonal ntibody 
to gp70 and the antiserum to p15E, similar titration 
curves were obtained, which should indicate that the 
number of the two molecules were of the same magnitude. 
We would have expected the number ofp 15E molecules to 
exceed that of gp70 due to the great 19ss of gpT0. 
The FeLV ISCOMs produced as described here, readily 
induced antibody to highly purified gp70 in mice (Figure 4) 
after two doses containing as little as 15 ng gp70. The 
specificity of the antibody was confirmed in Western blot. 
It would, of course, be interesting to test in the natural 
host, i.e. the cat. Such experiments are presented in a 
subsequent paper 5. 
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